Growth Metrics

Acadia Pharmaceuticals (ACAD) EBIT Margin (2010 - 2026)

Acadia Pharmaceuticals' quarterly EBIT Margin came in at 1.72% in Q1 2026, down 962.0% year-on-year from 0.2% in Q1 2025, and up 91.58% quarter-over-quarter from 20.46% in Q4 2025.

Acadia Pharmaceuticals has reported EBIT Margin for 17 years, with the latest figure at 1.72% in Q1 2026.

  • For the quarter ending Q1 2026, EBIT Margin fell 962.0% year-over-year to 1.72%; the trailing twelve-month figure through Mar 2026 stood at 0.49% (down 2308.0% YoY), and the FY2025 full-year result was 2.74%, down 2136.0% from the prior year.
  • EBIT Margin for Q1 2026 stood at 1.72%, up from 20.46% in the prior quarter.
  • The five-year high for EBIT Margin was 59.13% in Q4 2024, with the low at 97.88% in Q1 2022.
  • Average EBIT Margin over 5 years is 7.84%, with a median of 1.84% recorded in 2023.
  • Year-over-year, EBIT Margin sank 10304 bps in 2022 and surged 5264 bps in 2023.
  • Tracing ACAD's EBIT Margin over 5 years: stood at 33.75% in 2022, then soared by 145 bps to 15.12% in 2023, then jumped by 291 bps to 59.13% in 2024, then sank by 135 bps to 20.46% in 2025, then surged by 92 bps to 1.72% in 2026.
  • The last three EBIT Margin figures came in at 1.72% (Q1 2026), 20.46% (Q4 2025), and 12.83% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -6.43%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 38.10%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 17.83%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 23.02%
10 Acadia Pharmaceuticals 3.69 Bn 2.84 Bn 243.27 Mn -1.72%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1.72%
Dec 31, 2025 -20.46%
Sep 30, 2025 12.83%
Jun 30, 2025 12.24%
Mar 31, 2025 7.90%
Dec 31, 2024 59.13%
Sep 30, 2024 12.64%
Jun 30, 2024 12.58%
Mar 31, 2024 7.39%
Dec 31, 2023 15.12%
Sep 30, 2023 -27.29%
Jun 30, 2023 1.84%
Mar 31, 2023 -45.23%
Dec 31, 2022 -33.75%
Sep 30, 2022 -23.61%
Jun 30, 2022 -25.01%
Mar 31, 2022 -97.88%
Dec 31, 2021 69.29%
Sep 30, 2021 -11.63%
Jun 30, 2021 -37.93%
Mar 31, 2021 -62.66%
Dec 31, 2020 132.57%
Sep 30, 2020 -71.24%
Jun 30, 2020 -39.97%
Mar 31, 2020 -99.39%
Dec 31, 2019 -57.36%
Sep 30, 2019 -48.02%
Jun 30, 2019 -68.61%
Mar 31, 2019 -139.19%
Dec 31, 2018 216.45%
Sep 30, 2018 -105.09%
Jun 30, 2018 -112.30%
Mar 31, 2018 -112.18%
Dec 31, 2017 -160.71%
Sep 30, 2017 -184.51%
Jun 30, 2017 -223.25%
Mar 31, 2017 -580.41%
Dec 31, 2016 -654.00%
Sep 30, 2016 -1,374.32%
Jun 30, 2016 -74,147.42%
Mar 31, 2016 -1,256,550.00%
Dec 31, 2015 372,047.06%
Sep 30, 2015 -99,994.87%
Jun 30, 2015 -3,949,700.00%
Mar 31, 2015 -1,013,800.00%
Dec 31, 2014 70,712.77%
Sep 30, 2014 -166,626.67%
Jun 30, 2014 -77,582.14%
Mar 31, 2014 -59,860.00%
Dec 31, 2013 35,759.46%
Sep 30, 2013 -4,504.58%
Jun 30, 2013 -2,030.38%
Mar 31, 2013 -1,478.18%
Dec 31, 2012 -1,794.47%
Sep 30, 2012 -69.21%
Jun 30, 2012 -906.34%
Mar 31, 2012 -1,384.67%
Dec 31, 2011 -903.74%
Sep 30, 2011 -872.09%
Jun 30, 2011 -1,431.30%
Mar 31, 2011 -1,347.36%
Dec 31, 2010 83.95%
Sep 30, 2010 -184.35%